AAV gene therapy with cholesterol 24-hydroxylase attenuates Alzheimer phenotype in APP23 mice

被引：0

作者：

Hudry, Eloise ^{[1
]}

Van Dam, Debby ^{[2
]}

Kulik, Wim ^{[3
]}

De Deyn, Peter Paul ^{[2
]}

Stet, Femke ^{[3
]}

Ahouansou, Ornella ^{[1
]}

Benraiss, Abdellatif ^{[1
]}

Delacourte, Andre ^{[4
]}

Bougneres, Pierre ^{[5
]}

Aubourg, Patrick ^{[1
]}

Cartier, Nathalie ^{[1
]}

机构：

[1] Hop St Vincent de Paul, INSERM, U745, F-75674 Paris, France

[2] Univ Antwerp, Lab Neurochem & Behav, Dept Biomed Sci, Antwerp, Belgium

[3] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands

[4] JPARC, U837, Inserm, Lille, France

[5] Hop St Vincent de Paul, INSERM, U651, F-75674 Paris, France

来源：

HUMAN GENE THERAPY | 2008年 / 19卷 / 10期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：1085 / 1086

页数：2

共 50 条

[1] AAV Gene Therapy with Cholesterol 24-Hydroxylase Reverses Alzheimer Phenotype of APP23 Mouse Model
Hudry, Eloise
Van Dam, Debby
Kulik, Wim
De Deyn, Peter P.
Stet, Femke F.
Ahouansou, Ornella
Benraiss, Abdellatif
Delacourte, Andre
Bougneres, Pierre
Aubourg, Patrick
Cartier, Nathalie
MOLECULAR THERAPY, 2009, 17 : S148 - S148
[2] AAV Gene Therapy with Cholesterol 24-Hydroxylase for Alzheimer Disease: In Vivo Consequences on Amyloid and Tau Components of the Pathology
Gautier, Benoit
Burlot, Marie Anne
Blum, David
Hudry, Eloise
Ayciriex, Sophie
Troquier, L.
Zommer, N.
Caillerez, R.
Auzeil, Vincent
Braudeau, Jerome
Laprevote, Olivier
Pradier, Laurent
Aubourg, Patrick
Buee, Luc
Cartier, Nathalie
MOLECULAR THERAPY, 2012, 20 : S30 - S31
[3] AAV gene therapy for Alzheimer disease: Consequences of AAV-mediated CHOLESTEROL 24-HYDROXYLASE overexpression in THY-TAU22 mouse model.
Burlot, Marie-Anne
Blum, David
Braudeau, Jerome
Ayciriex, Sophie
Bieche, Ivan
Varin, Jennifer
Gautier, Benoit
Troquier, Laetitia
Zommer, Nadege
Caillerez, Raphaelle
Pradier, Laurent
Aubourg, Patrick
Laprevote, Olivier
Auzeil, Nicolas
Buee, Luc
Cartier, Nathalie
HUMAN GENE THERAPY, 2012, 23 (10) : A37 - A37
[4] Differential expression of cholesterol 24-hydroxylase and cholesterol 27-hydroxylase in Alzheimer's disease
Wolozin, B
Brown, J
Silberman, S
Theisler, C
Yager, D
Crawley, J
Magnuson, D
Reiss, A
Lee, JM
NEUROBIOLOGY OF AGING, 2004, 25 : S529 - S529
[5] Cholesterol 24-hydroxylase and apolipoprotein E gene polymorphisms in Alzheimer's disease in Hungarian population
Juhász, A
Rimanóczy, A
Zana, M
Bjelik, A
Kálmán, J
Gálfi, M
Janka, Z
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S609 - S609
[6] Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover
Lund, EG
Xie, CL
Kotti, T
Turley, SD
Dietschy, JM
Russell, DW
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (25) : 22980 - 22988
[7] Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease
Desai, P
DeKosky, ST
Kamboh, MI
NEUROSCIENCE LETTERS, 2002, 328 (01) : 9 - 12
[8] Polymorphisms of the cholesterol 24-hydroxylase (CYP46A1) gene and the risk of Alzheimer's disease in a Chinese population
Ma, Suk Ling
Tang, Nelson Leung Sang
Lam, Linda Chiu Wa
Chiu, Helen Fung Kum
INTERNATIONAL PSYCHOGERIATRICS, 2006, 18 (01) : 37 - 45
[9] The Evolution of Aβ Peptide Burden in the APP23 Transgenic Mice: Implications for Aβ Deposition in Alzheimer Disease
Yu-Min Kuo
Thomas G. Beach
Lucia I. Sue
Sarah Scott
Kathryn J. Layne
Tyler A. Kokjohn
Walter M. Kalback
Dean C. Luehrs
Tatiana A. Vishnivetskaya
Dorothee Abramowski
Christine Sturchler-Pierrat
Matthias Staufenbiel
Roy O. Weller
Alex E. Roher
Molecular Medicine, 2001, 7 : 609 - 618
[10] The evolution of Aβ peptide burden in the APP23 transgenic mice:: Implications for Aβ deposition in Alzheimer disease
Kuo, YM
Beach, TG
Sue, LI
Scott, S
Layne, KJ
Kokjohn, TA
Kalback, WM
Luehrs, DC
Vishnivetskaya, TA
Abramowski, D
Sturchler-Pierrat, C
Staufenbiel, M
Weller, RO
Roher, AE
MOLECULAR MEDICINE, 2001, 7 (09) : 609 - 618

← 1 2 3 4 5 →